Euro Chemo-Pharma acquired by IMCD Malaysia

Wednesday, 31 May, 2023

IMCD Malaysia has acquired Euro Chemo-Pharma with the aim of accelerating growth in life science markets.

IMCD, a distributor, formulator and solutions provider of speciality chemicals and ingredients, has announced that an agreement to acquire 100% of the shares of the speciality distribution company Euro Chemo-Pharma and its wholly owned subsidiary, Biofresh Green, has been signed.

“Euro Chemo-Pharma’s strategic positioning is fully aligned with IMCD, providing us the complementary portfolio to accelerate growth in the Malaysian market,” remarked Andreas Igerl, President at IMCD APAC.

“In addition, we aim to leverage the suppliers’ synergies we gain from them to develop further our life science business in the Asia–Pacific markets,” Igerl concluded.

Euro Chemo-Pharma was founded in Malaysia in 1975, offering a wide range of products including food, pharmaceutical and personal care applications. Headquartered in Penang, with offices and warehouses also in Kuala Lumpur and Johor, it ensures the full coverage of the Malaysian market.

The company also represents leading global suppliers providing its customers with an extensive portfolio backed by in-depth formulation expertise. With a generated revenue of approximately MYR 270 million (approx AU$90 million) in the financial year that ended on June 30, 2022, Euro Chemo-Pharma adds approximately 124 employees to the IMCD Malaysia team and an application laboratory in Penang.

Euro Chemo-Pharma’s subsidiary, Biofresh, includes blending, mixing and compounding of food and flavour ingredients and holds the Halal certification.

“We have managed to grow the company to be the largest and most efficient speciality ingredients distributor in Malaysia,” commented Jeryl Tan, Executive Director at Euro Chemo-Pharma.

“With the mindset that if you don’t step forward, you are always in the same place, we believe that IMCD would be our best partner in the journey to drive growth and provide an exciting new home for our people,” Tan concluded.

The closing of the transaction is subject to customary closing conditions and is expected to take place in the last quarter of 2023.

Image caption: L–R: Fenna van Zanten, M&A Director of IMCD Group; Jeryl Tan, Executive Director of Euro Chemo-Pharma; Teoh Seok Har, Director of Euro Chemo-Pharma; Tan Hooi Pheng, Founder and Managing Director of Euro Chemo-Pharma; Andreas Igerl, President of IMCD APAC; Vivien Tan, Executive Director of Euro Chemo-Pharma: Sylvia Tan, Shareholder of Euro Chemo-Pharma; Emmanuel Colette, APAC Business Group Director of IMCD Food & Nutrition. Image: Supplied.